Page last updated: 2024-10-22

tyrphostin ag 1024 and Hyperglycemia, Postprandial

tyrphostin ag 1024 has been researched along with Hyperglycemia, Postprandial in 1 studies

tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor

Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, S1
Yanai, M1
Yamaguchi, S1
Couraud, PO1
Ohtsuki, S1

Other Studies

1 other study available for tyrphostin ag 1024 and Hyperglycemia, Postprandial

ArticleYear
Regulation of Tight-Junction Integrity by Insulin in an In Vitro Model of Human Blood-Brain Barrier.
    Journal of pharmaceutical sciences, 2017, Volume: 106, Issue:9

    Topics: Astrocytes; Biological Transport; Blood-Brain Barrier; Brain; Cell Culture Techniques; Cell Prolifer

2017